Tag: LINC
Aspirex achieves 78% two-year primary patency rate in P-MAX postmarket observational...
At the Leipzig Interventional Course (LINC) 2024 (May 28–31, Leipzig, Germany), Michael Lichtenberg (Arnsberg Vascular Clinic, Arnsberg, Germany) shared for the first time a...
VeinWay reports second human compassionate use of Traversa for venous recanalisation
In a second compassionate use case, interventional vascular surgeon Stefan Stalhoff of Klinikum Hochsauerland (Arnsberg, Germany) used VeinWay's Traversa for venous recanalization to save a...